BOSTON, Aug. 31, 2016 /PRNewswire/ -- Juniper
Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the
"Company"), announced today that Alicia
Secor, President and Chief Executive Officer, will present
at the Rodman & Renshaw 18th Annual Global Investment
Conference, sponsored by H.C.
Wainwright & Co., LLC., as follows:
Event:
|
18th Annual Rodman
& Renshaw Global Investment Conference
|
|
|
Date:
|
Monday, September 12,
2016
|
|
|
Time:
|
9:35 a.m. EDT
|
|
|
Location:
|
Kennedy II (4th
Floor), Lotte New York Palace Hotel, NYC
|
Juniper's presentation will be webcast live via
www.juniperpharma.com under the 'Investors' tab, or click
here. The webcast will be archived for 90 days at the
aforementioned URLs.
In addition to the live presentation, Ms. Secor and George O. Elston, Juniper's Chief Financial
Officer, will be available for one-on-one meetings with investors
who are registered to attend the conference.
Institutional investors wishing to attend Juniper's presentation
may visit www.rodmanevents.com to register for the Rodman &
Renshaw conference. Once your registration is confirmed, you
will be prompted to log into the conference website to request a
one-on-one meeting with the Company.
About Juniper
Pharmaceuticals
Juniper Pharmaceuticals, Inc. is focused on
developing therapeutics to address unmet medical needs in women's
health. The Company is advancing a pipeline of proprietary
product candidates that leverage its differentiated intravaginal
ring technology and the 505(b)(2) regulatory pathway.
Juniper's core operating business includes the
Crinone® (progesterone gel) franchise and Juniper
Pharma Services, which provides high-end fee-for-service
pharmaceutical development and clinical trials manufacturing to
clients. Please visit www.juniperpharma.com for more
information.
Juniper Pharmaceuticals™ is a trademark of Juniper
Pharmaceuticals, Inc., in the U.S. and EU.
Crinone® is a registered trademark of Merck KGaA,
Darmstadt, Germany, outside the
U.S. and of Allergan, Inc. in the U.S.
Contact
Amy Raskopf
Director, Corporate Communications, Juniper Pharmaceuticals,
Inc.
(917) 673-5775 / ir@juniperpharma.com
To receive Juniper's press releases, SEC filings or calendar
alerts by email click here.
Follow us
on LinkedIn
Logo - http://photos.prnewswire.com/prnh/20150527/218998LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-present-at-rodman--renshaw-global-investment-conference-on-september-12-2016-300320814.html
SOURCE Juniper Pharmaceuticals, Inc.